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<H1> Summary  
The effectiveness of transcutaneous electrical nerve stimulation (TENS) for pain relief has been 
challenged. This article evaluates systematic review findings and demonstrates that studies using 
appropriate TENS technique and dosage are more likely to demonstrate efficacy. Therefore, it seems 
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<H1> Short Title  




The use of electrical stimulation of the skin for symptomatic relief of pain is an age-old technique 
with the ancient Egyptians (circa 2500 B.C.) and the ancient Romans (circa 15 A.D.) using live electric 
fish placed on the skin to relieve pain for various ailments (Gildenberg, 2006). Nowadays, electrical 
stimulation of the skin is achieved using battery operated devices that generate pulsed currents that 
are delivered across the intact surface of the skin using self-adhering electrodes and lead wires 
(Figure 1). The technique is called transcutaneous electrical nerve stimulation (TENS). The goal of 
TENS is to stimulate peripheral nerves as this has been shown to reduce transmission of pain-related 
information in a manner similar to rubbing the skin (Johnson and Bjordal 2011). Therefore, TENS is 
used to “electrically rub pain away”.  
 
[Figure 1 - TENS and accessories] 
 
TENS is used as an adjunct to core treatment for symptomatic relief of inflammatory, neuropathic 
and musculoskeletal pain. TENS can be used as a stand-alone treatment for mild to moderate pain 
and in combination with medication for moderate to severe pain. It is popular with patients and 
practitioners because it is safe, non-invasive, inexpensive, easy to self-administer, and pain relief is 
rapid in onset. There is no potential for toxicity or overdose so patients can titrate dosage as 
needed. TENS devices and accessories (lead-wires, electrodes and batteries) can be purchased at 
pharmacies or via the internet without prescription for £15 to £100 GBP. TENS may be prescribed by 
health care professionals depending on local policy. Nurses, midwifes and physiotherapists often 
support patients in the use of TENS. 
 
Uncertainty about the usefulness of TENS has persisted for decades due in part to varied 
recommendations by expert panels. For example, the UK National Institute for Health and Clinical 
Excellence (NICE) recommend that TENS should be offered for short-term relief of osteoarthritic 
knee pain (National Institute for Health and Clinical Excellence 2008), rheumatoid arthritis of the 
hand (National Institute for Health and Clinical Excellence 2009a) and musculoskeletal pain 
secondary to multiple sclerosis (National Institute for Health and Clinical Excellence 2003) but not for 
persistent non-specific low back pain (National Institute for Health and Clinical Excellence 2009b), 
pain during established labour (National Institute for Health and Clinical Excellence 2007) or angina 
(National Institute for Health and Clinical Excellence 2011). Recently, the Centers for Medicare and 
Medicaid Services in the USA, decided that there was insufficient strong evidence that TENS was 
effective for chronic low back pain and discontinued insurance coverage until evidence from an 
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suitably robust randomized controlled clinical trial (RCT) showed otherwise (Jacques et al 2012). The 
aim of this article is to determine whether there is a case to support the continued use of TENS by 
critically reviewing clinical research and exploring reasons for inconsistency in clinical guidelines.  
 
<H1> Principles and practice of TENS  
Many myths and opinions remain about how best to use TENS in clinical practice, fueled in part by 
the assortment of combinations of electrical output characteristics available on even the simplest of 
TENS devices (Figure 2). A detailed description of technique can be found by Johnson (2012) and in a 
forthcoming textbook (Johnson 2014). A brief summary of appropriate TENS technique is provided 
here. 
 
[Insert Figure 2 here] 
 
<H2> TENS techniques 
Two TENS techniques are commonly employed in practice.  
a) Conventional TENS using high frequency, low intensity currents to generate a strong, non-
painful TENS sensation without muscle contractions at the site of pain or in related 
dermatomes  
b) Acupuncture-like TENS (AL-TENS) using low frequency, high intensity currents to generate 
non-painful phasic muscle contractions (twitching) at the site of pain or in related myotomes 
Conventional TENS is the method of choice in most instances, with AL-TENS reserved for patients 
who do not respond to conventional TENS. There are some circumstances when AL-TENS may be 
selected before conventional TENS including the presence of altered skin sensitivity, radiating pain, 
pain arising from deep structures and widespread or multiple site pain. AL-TENS requires a greater 
understanding of physiological principles to administer appropriately. Patients taking regular opioid 
medication may respond less well to AL-TENS because the actions of AL-TENS are mediated via the 
release of endogenous opioids and animal studies have found a role for spinal opioid receptors in 
the development of tolerance to TENS analgesia (Chandran and Sluka, 2003).   
 
Appropriate electrode positioning and sufficiently strong TENS is critical to success. For both 
techniques electrodes should be placed on healthy innervated skin where sensation is intact. A 
systematic trial and error approach is taken to find optimal positions. For conventional TENS 
electrodes should be positioned so that the TENS sensation covers the painful area and this is usually 
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achieved by applying electrodes on the outer margins of the pain (Figure 3). This may not be possible 
when  
 it is difficult to attach electrodes to body parts e.g. hands, feet, body creases 
 there is altered skin sensation or a skin lesion over the site of pain 
 a body part  is absent e.g. phantom limb pain 
In these instances electrodes are placed over the main nerves proximal to the site of pain, or close to 
vertebrae of spinal segments, over contralateral dermatomes, over acupuncture points (acu-TENS) 
and over trigger points. 
 
[Insert Figure 3 here] 
 
A sufficiently strong TENS sensation is critical for the success of conventional TENS (Moran et al 
2011). To achieve this patients are instructed to increase the pulse amplitude of the currents to 
attain a strong yet non-painful TENS sensation. There is insufficient consistent evidence from clinical 
studies to support prescribing other electrical characteristics including pulse frequencies, durations 
and patterns so selection is made by the patient according to what is most comfortable for them at 
that moment in time. Repeated daily use of TENS may cause analgesic tolerance which may be 
overcome by increasing the intensity of TENS each day or by changing the electrical characteristics of 
stimulation. 
 
There are no reliable predictors of success so any type of pain may respond to TENS. It is important 
to conduct a supervised trial to screen for suitability and to familiarize the patient with safe and 
appropriate technique including selecting appropriate electrode positions and electrical 
characteristics. Generally, TENS can be used with little risk for most patients but if there is concern 
then the situation must be discussed with the patient and their physician and all risks and 
consequences disclosed. 
 
<H2> Contraindications and precautions 
Safety guidelines have been published by professional bodies to guide clinical judgments about the 
suitability of TENS (e.g. the Australian Physiotherapy Association (Robertson et al 2001), the 
Chartered Society of Physiotherapy in the United Kingdom (Chartered Society of Physiotherapy 
2006), and the Canadian Physiotherapy Association (Houghton et al 2010). Manufacturers identify 
cardiac pacemakers, pregnancy, and epilepsy as contraindications because it may be difficult from a 
medico-legal perspective to exclude TENS as contributing to a problem. However, there is limited 
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research evidence directly linking TENS to adverse events in these cases so some practitioners have 
used TENS providing it is not administered over the area of concern and the progress of the patient 
is monitored carefully.   
 
Before using TENS it is important to check whether the patient has an implant or external 
attachment (e.g. drainage system). If so, it is necessary to ascertain whether electrical currents from 
TENS could interfere with operation of the implant or cause mechanical stresses in tissues by TENS-
induced muscle contraction or blood vessel constriction or dilatation. For example, an implanted 
electrical device may need to discriminate between true electrical activity from biological tissue such 
as the heart and the electrical current generated by the TENS device. If TENS caused a malfunction of 
such a device it could be life-threatening. For this reason TENS is contraindicated for patients with  
cardioverter defibrillators because there is strong evidence that TENS causes interferes with their 
functioning. TENS is also contraindicated for cardiac pacemakers, although Carlson et al (2009) have 
used TENS for individuals with cardiac pacemakers. They have developed a ECG testing and 
monitoring procedure performed during the first application of TENS and recommended that 
patients are contraindicated if it is not possible for the pacemaker rate to override a spontaneous 
tachycardia or if there is an absence of ventricular inhibited (ventricular demand, VVI) pacing of at 
least 40 bpm. Cardiologists must be involved in all decisions about the possibility of using TENS in 
these circumstances.  
 
TENS may be used as part of a rehabilitation package after joint replacement surgery. There are no 
known reports of adverse events for TENS although a mild skin burn has been reported during the 
use of interferential current therapy (a TENS-like device) over a metal implant following 
unicompartmental knee arthroplasty (Ford et al 2005). When using TENS for pain associated with 
stents, percutaneous drainage systems, and central venous catheters it is advisable that low-
intensity conventional TENS without muscle contractions is used so that mechanical stresses to 
surrounding tissue are kept at an absolute minimum. Careful monitoring is critical when using TENS 
in all of these situations.  
 
TENS should not be administered over the abdomen in pregnancy, the head in epilepsy, or over 
areas where there is deep vein thrombosis, recent haemorrhage or damaged skin, including skin 
with altered sensitivity. TENS should not be delivered over areas where there is active malignancy 
for patients with ‘treatable’ tumours in acute oncology settings because the effect of TENS on 
cancerous tissue is not known. However, TENS may be used in palliative setting under the 
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supervision of a palliative care specialist. TENS should not be used on irradiated skin in the 
immediate weeks after radiotherapy. 
 
Hazardous electrode sites include the anterior neck over the carotid sinus, transorbital (i.e. across 
the eyes), transthoracic (i.e. using electrodes on the front and back of the chest) and transcranial 
(i.e. using electrodes on the right and left temple)(Figure 4).  
 
[Insert Figure 4 here] 
 
The importance of educating patients, investigators and practitioners about appropriate TENS 
technique and to put in places processes to monitor adherence cannot be over emphasised. 
Recently, an observational study found that patients with chronic low back pain did not follow 
instructions from research investigators about how often and for how long to self-administer TENS 
at home (Pallett et al 2013). Furthermore, pain is often used as the primary outcome, although it is 
amorphous and notoriously difficult to measure reliably. Therefore, treatment goals should be 
framed as measureable functional outcomes that can monitor progress and can be verified with 
quantifiable changes in behaviour and quality of life. 
 
<H1> Evidence for the effectiveness of TENS 
Published research literature on TENS is vast with the number of hits increasing on a yearly basis 
(Figure 5).  An unfiltered search in PubMed on 18 October 2013 using the Medical Subject Header 
(MeSH) ‘transcutaneous electric nerve stimulation’ yielded 6039 hits. Most of the clinical research 
comprises cohort studies, case-series and clinical trials without controls and the majority of these 
studies find that TENS reduces pain. However, the lack of suitable control groups means that 
observations of pain relief from TENS may be contaminated by expectation of treatment success and 
non-specific effects of the practitioner-patient encounter. Randomized controlled clinical trials 
(RCTs) are studies that attempt to remove bias associated with non-specific treatment effect so the 
effect of the “active ingredient” of the treatment can be evaluated (i.e. efficacy). Often RCTs 
compare a treatment with a placebo that has no active ingredient but is indistinguishable from the 
treatment. This enables investigators to conceal (blind) the treatment and placebo from trial 
participants and outcome assessors, reducing biases associated with the expectation that a 
treatment will be beneficial. 
 




Randomized placebo-controlled clinical trials of TENS determine whether electrical currents used 
during TENS contribute to clinical outcome. They answer the question “Do you need to put batteries 
in the TENS device to get beneficial effects?” A PubMed search on 18 October 2013 limited to 
randomized controlled clinical trials yielded 1006 hits. Systematic reviews are used to identify, 
appraise and synthesize the findings of RCTs and they may include meta-analyses that combine 
(pool) data from each RCT to estimate the overall size of the treatment effect. Systematic reviews 
and meta-analyses of RCTs are top of the hierarchy of clinical research evidence when determining 
efficacy and/or effectiveness. 
 
The first systematic reviews on TENS were published in 1996 and they challenged the belief at the 
time that TENS was efficacious for acute and chronic pain (Carroll et al 1996, Reeve et al 1996) 
(Table 1). Since then there has been a proliferation of systematic reviews, many using methodology 
of the Cochrane collaboration (Cochrane reviews). Many systematic reviews have found that 
research is either inconclusive or conflicting, highlighting the difficulty of making sense of the 
evidence. 
 
[Insert Table 1 here] 
 
<H2> TENS for Acute Pain 
The most recent Cochrane review on TENS as a sole treatment for acute pain (<12 weeks) in adults 
was inconclusive (Walsh et al 2009). Many RCTs were excluded from the review because it was 
impossible to isolate the effect of TENS because participants were combining other treatments with 
TENS.  
 
<H3> TENS for Post-operative Pain 
The first systematic review on TENS for post-operative pain found TENS to be superior to placebo in 
17 of 19 non-RCTs but no different to placebo in 15 of 17 RCTs (Carroll et al 1996). It was concluded 
that TENS was not effective and that non-RCTs overestimated treatment effects, although the 
effects of TENS may have been masked in part by participants also consuming analgesic medication. 
The first meta-analysis on TENS was conducted in 2003 and found that TENS reduced post-operative 
consumption of analgesic medication to a greater extent than placebo TENS (Bjordal et al 2003). 
Larger effects were observed in the 11 RCTs that used adequate TENS technique defined as ‘‘strong, 
definite, sub noxious, maximal tolerable… within or close to site of pain” compared with 9 RCTs that 
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did not. More recently, evidence from systematic reviews suggests that TENS in combination with 
analgesic medication is superior to placebo TENS in combination with analgesic medication for the 
relief of thoracotomy or post-sternotomy pain (Freynet and Falcoz 2010, Sbruzzi et al 2012)(Table 1).  
 
<H3> TENS for Labour Pain 
Despite widespread use of TENS for pain during childbirth, systematic reviews have failed to find 
conclusive evidence of TENS efficacy, although there is tentative evidence that women receiving 
TENS are more “satisfied” than those receiving placebo (Bedwell et al 2011, Carroll et al 1997; 
Dowswell et al 2009, Mello et al 2011, Reeve et al 1996). RCT findings are conflicting with most RCTs 
not evaluating TENS in the early stages labour where it is more likely to be effective. 
 
<H3> TENS for Dysmenorrhoea, Angina and other acute pains  
There is weak evidence from a Cochrane review that high but not low frequency TENS was superior 
to placebo for primary dysmenorrhoea (Proctor et al 2003) and tentative evidence from RCTs with 
small samples sizes that TENS reduces angina pectoris-like chest pain and pain from lacerations, 
fractures, hematomas, contusions and dental procedures (de Vries et al 2007). 
 
<H1> TENS for Chronic Pain 
In 2008, Claydon and Chesterton (2008) evaluated six systematic reviews on TENS for chronic low 
back pain, osteoarthritis of the knee, rheumatoid arthritis of the hand, chronic musculoskeletal pain, 
and miscellaneous chronic pain. They found evidence in three reviews that TENS was superior to 
placebo and that higher intensities of TENS generated greater pain relief. The most recent Cochrane 
review for chronic pain was inconclusive (Nnoaham and Kumbang 2008) and the most recent 
Cochrane review on TENS for cancer pain found insufficient RCTs to make a meaningful judgment on 
efficacy (Hurlow et al 2012).   
 
<H2> TENS for Neuropathic Pain  
There are few RCTs on TENS for neuropathic pain with no Cochrane reviews published to date. 
Systematic reviews provide tentative evidence that TENS relieves peripheral neuropathy (Jin et al  
2010, Dubinsky and Miyasaki 2010), post-stroke pain (Price and Pandyan 2001) and spinal cord injury 
(Fattal et al  2009). There were insufficient RCTs to make a judgment for post-amputation pain 
(Mulvey et al 2010), although case-series are promising (Mulvey et al 2012). In 2007, the European 
Federation of Neurological Societies Task Force for neurostimulation therapy for neuropathic pain 
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recommended that TENS should be offered as a preliminary or add-on therapy for neuropathic pain, 
although evidence that TENS was superior than placebo was weak (Cruccu et al 2007). 
 
<H2> TENS for Chronic Musculoskeletal Pain 
To date the largest meta-analysis on TENS evaluated efficacy for chronic musculoskeletal pain and 
provided strong evidence that pain relief during TENS was three times that seen by placebo (Johnson 
and Martinson 2007). Cochrane reviews on TENS for neck pain (Kroeling et al 2009), chronic, 
recurrent headache (Bronfort et al 2004) and rheumatoid arthritis of the hand (Brosseau et al 2003), 
provide only weak evidence for efficacy. RCTs with small sample sizes offer tentative evidence of 
efficacy for fibromyalgia (Lauretti et al  2013, Carbonario et al  2013, Lofgren and Norrbrink 2009,  
Mutlu et al  2013), myofascial pain syndrome (Rodriguez-Fernandez et al 2011, Gemmell and Hilland 
2011, Hou et al  2002) and epicondylitis (Weng et al 2005). Recently, a well-designed RCT found that 
TENS did not provide additional pain relief when administered as an adjunct to primary care 
management for tennis elbow, although this may have been due in part to participants not following 
instructions for optimal self-administered TENS treatment (Chesterton et al 2013). 
 
<H3> TENS for Osteoarthritis 
A meta-analysis of 7 RCTs using adequate TENS technique found that TENS was superior to placebo 
with reductions in pain of 22.2 mm (95% confidence interval = 18.1 to 26.3) on a 100 mm visual 
analogue scale (Bjordal et al 2007). The most recent Cochrane review of TENS for osteoarthritis of 
the knee(s) included a meta-analysis of 16 RCTs and found that TENS (including interferential current 
therapy) reduced pain by 21mm compared with control groups (Rutjes et al 2009). However, when 
small methodologically weak RCTs were removed from the analysis the size of pain relief became 
negligible and the reviewers decided that evidence was inconclusive. Recently, a well-designed RCT 
found that TENS conferred no additional benefits to education and exercise (Palmer et al 2013). 
 
<H3> TENS for Chronic Low Back Pain 
The most recent Cochrane review on TENS for low back pain was inconclusive (Khadilkar et al 2008) 
and the most recent meta-analysis found no difference between TENS and placebo, although there 
were too few RCTs to make a reliable judgment (van Middelkoop et al 2011). Many systematic 
reviews on TENS for chronic low back pain have been conducted as part of projects to develop 
clinical practice guidelines with claims that TENS is efficacious (Airaksinen et al 2006, Poitras and 
Brosseau 2008), not efficacious (Dubinsky and Miyasaki 2010, Jacques et al 2012, Philadelphia Panel 
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2001) or of unknown efficacy (Chou and Huffman 2007, National Institute for Health and Clinical 
Excellence 2009b).  
 
<H1> Dangers of accepting clinical practice guidelines on TENS on face value 
Clinical practice recommendations on the use of TENS for chronic low back pain have a major impact 
on the perception of TENS treatment in general. In the UK, NICE recommended “Do not offer 
Transcutaneous electric nerve stimulation (TENS) [for early management of persistent non-specific 
low back pain]” (National Institute for Health and Clinical Excellence 2009b: p133) and in the USA, 
the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology 
stated that “Transcutaneous electric nerve stimulation (TENS) is not recommended for the 
treatment of chronic low back pain (Level A [evidence])” (Dubinsky and Miyasaki 2010: p173). In 
2012, the Centers for Medicare and Medicaid Services in the USA concluded that “TENS is not 
reasonable and necessary for the treatment of chronic low back pain” and discontinued insurance 
coverage unless beneficiaries were enrolled on a RCT (Jacques et al 2012). Yet in the same year the 
American Society of Anesthesiologists Task Force on Chronic Pain Management and the American 
Society of Regional Anesthesia and Pain Medicine recommended that “TENS should be used as part 
of a multimodal approach to pain management for patients with chronic back pain and may be used 
for other pain conditions (e.g. neck and phantom limb pain).” (American Society of Anesthesiologists 
2010: p816).  
 
The contradictory nature of evidence and professional and regulatory body recommendations 
creates uncertainty for practitioners. Furthermore, the fact that there are more systematic reviews 
than RCTs on TENS for chronic low back pain should raise serious concern about the evidence on 
which recommendations are based. A critical evaluation by the Therapeutics and Technology 
Assessment Subcommittee of the American Academy of Neurology provides an insight to 
methodological shortcomings in many systematic reviews on TENS. The Therapeutics and 
Technology Assessment Subcommittee of the American Academy of Neurology concluded that 
“TENS is established as ineffective [for chronic low back pain]” (Dubinsky and Miyasaki, 2010: p174). 
They claimed that this was based on Level A evidence consisting of two ‘good quality’ RCTs. 
Interestingly, only 114 participants received TENS and 87 received placebo (no current) TENS in 
these two RCTs. One of the RCTs (Deyo et al 1990) was criticized at the time of publication because 
TENS technique and dose were considered to be inadequate. There was concurrent use of hot packs 
in all treatment arms that may have masked the effects of TENS and participants in the placebo TENS 
group reported improvements in pain that lasted up to 2 months post intervention which seemed 
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unreasonably efficacious.  Participants were recruited via newspaper advertising and likely to be 
treatment resistant and not representative of chronic low back patients in general. Aetiologies were 
varied including neurological deficits (12%), nerve-root irritation (16%) and self-reported history of 
arthritis (30%). The other RCT found no differences between TENS and placebo TENS for chronic low 
back pain associated with multiple sclerosis although the investigators argued that clinically 
important improvements occurred during TENS but not placebo (Warke et al 2006). Participants in 
both groups had access to additional analgesics.  
 
The Therapeutics and Technology Assessment Subcommittee of the American Academy of 
Neurology also evaluated evidence for TENS and diabetic neuropathy and concluded that “TENS is 
probably effective in treating painful diabetic neuropathy (2 Class II studies)” (Dubinsky and 
Miyasaki, 2010: p173). They recommended that “TENS should be considered in the treatment of 
painful diabetic neuropathy (Level B [evidence])” (Dubinsky and Miyasaki, 2010: p173) although this 
was based on only 31 participants receiving TENS and 24 placebo TENS. Johnson and Walsh (2010) 
critiqued the assessment and summarized the situation as follows: “It seems unreasonable that the 
effectiveness of TENS, and subsequent clinical recommendations, can be established from studies 
with so few participants” (Johnson and Walsh 2010: p314). 
 
Basing clinical recommendations on such small data sets is not unique to TENS. (Machado et al  
2009) conducted a review of 34 treatments (76 RCTs) for non-specific chronic low back pain with 
total sample populations relatively low for most treatments including electroacupuncture (25 
participants: 1 RCT), acupuncture (149 participants: 4 RCTs), exercise (204: 3 RCTs), antidepressants 
(217 participants: 4 RCTs) and nerve blocks (17 participants: 1 RCT). Interestingly, the efficacy of 
TENS (178 participants: 4 RCTs) compared favourably with other treatments including muscle 
relaxants (820 participants: 9 RCTs) and non-steroidal anti-inflammatory drugs (1349 participants: 7 
RCTs), with a 10-20% reduction in pain from baseline.  
 
A review of the methodological quality of RCTs on TENS revealed that under-dosing and the use of 
inadequate TENS technique was common in RCTs (Bennett et al 2011). The reviewers developed 
methodological criteria and operational procedures to deliver an ‘ideal’ RCT on TENS and it is hoped 
that this will lead to improved design of RCTs in the future and to a more robust evidence base.  
 
 
<H1> Should TENS still be used? 
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This review demonstrates that recommendations from professional and government bodies that 
TENS should not be offered for certain painful conditions are based on a lack of good quality 
evidence to make a judgement about efficacy rather than good quality evidence that TENS is not 
effective. Meta-analyses of RCTs using appropriate TENS technique and dosage provide strong 
evidence that TENS is superior to placebo TENS for chronic musculoskeletal pain and for post-
operative pain, and moderate evidence that TENS is efficacious for neuropathic pain. In addition the 
general consensus from clinical experience is that TENS helps patients manage their pain. Therefore, 
it seems reasonable that nurses are able to offer TENS as an adjunct to core treatment for painful 
conditions especially as it is inexpensive and has a favourable safety profile compared with long term 
medication. Whether the costs of supplying TENS devices and accessories is covered by health care 
providers or patients is a matter for policy makers. Nevertheless, no matter how patients obtain 
TENS devices and accessories it is critical that nurses are in a position to educate patients about safe 
and appropriate TENS technique including the need for patients to regularly self-administer TENS.  
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<H1> Figure Legends 
 
Figure 1 
TENS and accessories used to manage chronic low back pain 
 
Figure 2 
Output characteristics of TENS devices commonly used in practice 
 
Figure 3 
Commonly used electrode positions for conventional TENS 
 
Figure 4 
Hazardous electrode positions for TENS. Shaded areas show general area of hazard where electrodes 
should never be positioned for certain conditions.   signifies dangerous electrode combinations.  
 
Figure 5 
 Number of ‘hits’ by year for an unfiltered PubMed search using the Medical Subject Header (MeSH) 
‘transcutaneous electric nerve stimulation’ on 18 October 2013. [search string: "transcutaneous 
electric nerve stimulation"[MeSH Terms] OR ("transcutaneous"[All Fields] AND "electric"[All Fields] 








<H1> Tables  
 
Table 1 
Summary of systematic reviews published in peer reviewed journals evaluating TENS for pain 
 
Reference Data set for TENS and 




Acute Pain     










Low quality studies with small 
sample sizes 




17 RCTs (786 patients) 
Descriptive analysis 
Evidence of no 
effect 
Patients allowed free access to 
analgesic medication in some 
RCTs 




21 RCTs (964 patients)  
Meta-analysis 
Evidence of effect  Demonstrated that adequate 
TENS technique critical for effect 
Freynet and 
Falcoz (2010) 
Post-thoracotomy pain  
9 RCTs (645 patients) 
Descriptive analysis 
Evidence of effect 
as adjuvant but 
not as standalone 
treatment  
 
Most studies low quality studies 
with small sample sizes 
TENS > placebo as adjuvant to 
opioids for acute post-
thoracotomy pain  
Sbruzzi et al 
(2012) 
Post thoracic surgery 
pain  
11 studies 
Evidence of effect TENS with medication > placebo 
with medication for 
thoracotomy and sternotomy  
Carroll et al 
(1997) 
Labour pain  
10 RCTs (877 patients) 
Descriptive analysis 
 
Evidence of no 
effect 
Comparison groups consisted of 
active and inactive 
interventions. Patients allowed 
free access to analgesic 
medication in some RCTs 
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Dowswell et al 
(2009) 
 
Labour pain  





Low quality studies 
Bedwell et al 
(2011) 
Update of 
Dowswell et al 
(2009) 
Labour pain  





Women receiving TENS to 
acupuncture points were less 
likely to report severe pain  
Women using TENS would use it 
again in a future labour 
Mello et al 
(2011) 
Labour pain  
9 studies (1076 women) 
Evidence of no 
effect  
TENS = placebo for pain relief 
and the need for additional 
analgesia  
Women using TENS would use it 
again in a future labour 
Proctor et al 
(2003) 
 
Primary dysmenorrhoea  




Evidence of effect 
but only for high 
frequency TENS  
Low quality studies with small 
sample sizes  
McIntosh and 
Hall (2011) 
Acute low back pain  
1 systematic review 
(Machado et al 2009) 
Insufficient 
evidence to judge 
Evidence was of low quality 
Abou-Setta et 
al (2011) 
Pain after hip fracture 
2 studies on TENS  
Insufficient 
evidence to judge 
Only 2 studies on TENS 
 
Chronic Pain 













Low quality studies with small 
sample sizes and possibility of 















Evidence of effect Criticised for using multiple 
diseases  creating heterogeneity 
Khadilkar et al 
(2008) 
 
Chronic low back pain 
(miscellaneous)  





evidence to judge 
Low quality studies with small 
sample sizes and possibility of 
under dosing TENS 
2 RCTS suggested TENS did not 





Chronic low back pain 
(miscellaneous) 
6 RCTs (375 patients) 
Descriptive analysis 
 
Evidence of effect Low quality studies with small 
sample sizes  
Machado et al 
(2009) 
Non-specific low back 
pain (acute and chronic) 
4 RCTS (178 patients), 2 
acute, 2 chronic 
Evidence of effect 
 
 
Low quality studies with small 
sample sizes 
Insufficient evidence to judge 
Chou (2010) 
 
Chronic low back pain 
(miscellaneous)  
1 systematic review  
(Khadilkar et al 2008) 
and 1 additional RCT  
Evidence 
inconclusive 
Available evidence very low 
quality. RCTs heterogeneous in 





Chronic low back pain 
(Painful neurological 
conditions) 
2 RCTs (201 patients) 
Descriptive analysis 
Evidence of no 
effect  
Small sample sizes and 
possibility of under dosing TENS 
Insufficient evidence to judge 
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Rutjes et al 
(2009)  
 
Knee osteoarthritis  





Low quality studies with small 
sample sizes with some RCTs not 
using standard TENS device 
Bjordal et al 
(2007) 
Knee osteoarthritis  
7 RCTs (414 patients) 
Meta-analysis 
TENS effective in 
short term 
Accounted for adequate TENS 
technique in analysis 
Brosseau et al 
(2003) 
 
Rheumatoid arthritis  
3 RCT (78 patients) 
Meta-analysis 
(Cochrane review) 
Evidence of effect  Low quality studies with small 
sample sizes  




Cancer pain and its 
treatment  




evidence to judge  
 
Low quality studies with small 
sample sizes and possibility of 
under dosing TENS  
Hurlow et al 
(2012) Update 
of Robb et al 
(2008) 
Cancer pain and its 
treatment  





evidence to judge 
Low quality studies with small 
sample sizes and possibility of 
under dosing TENS 





disorders and  
mechanical neck 
disorders)  




Evidence of effect 
but  low quality 
studies 
 
Low quality studies with small 
sample sizes and possibility of 
under dosing TENS. Included any 
surface electrical stimulation 
(ES) including microcurrent 
devices 
Insufficient evidence to judge 
 
Bronfort et al 
(2004) 
 





Low quality studies with small 
sample sizes and possibility of 





Insufficient evidence to judge 




3 RCTs (78 patients) 
Meta-analysis 
Evidence of effect  Low quality studies with small 
sample sizes. Used non-standard 
TENS devices 








3 RCTs (2 RCTs used in 
evaluation 55 patients)  
Descriptive analysis 
Evidence of effect 
 
 
Low quality studies with small 
sample sizes 
Insufficient evidence to judge 





3 RCTs + 1 retrospective 
analysis TENS (n=130 
participants) 
Evidence of effect 
(Level B) 
TENS > placebo three large 
studies and one small study 








4 RCTs (170 patients) of 





Low quality studies with small 
sample sizes and possibility of 
under dosing TENS 
2RCTs used TENS to produce 
muscle contractions 
Insufficient evidence to judge 




Various neuropathies  




Evidence of effect  
 
Low quality studies with small 
sample sizes  
Insufficient evidence to judge 
Mulvey et al 
(2010) 
 
Post amputation pain  




Insufficient evidence to judge 
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